๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases

โœ Scribed by Nancy Kemeny; John A. Conti; Elin Sigurdson; Alfred Cohen; Karen Seiter; Robert Lincer; Donna Niedzwiecki; Jose Botet; Douglass Chapman; Patricia Costa; Andrew Budd

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
733 KB
Volume
71
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Results of pharmacokinetic modulating ch
Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases
โœ Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Reigetsu Yoshikawa; Takehira Ya ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial

Hepatic chemoembolization combined with
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma : A Southwest Oncology Group pilot trial
โœ Cynthia Gail Leichman; Joth R. Jacobson; Manuel Modiano; John R. Daniels; Mark M ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 2 views

## BACKGROUND. Rates of response to systemic chemotherapy among patients with advanced colorectal carcinoma rarely exceed 25-30%, and complete responses are rare. The liver is the most common site of metastasis; however, regional therapies have not improved survival rates. The Southwest Oncology Gr